PIPA512519

EPCR Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA512519-Each-of-1 In Stock ₹ 48,905.50

PIPA512519 - Each of 1

₹ 48,905.50

In Stock

Quantity

1

Base Price: ₹ 48,905.50

GST (18%): ₹ 8,802.99

Total Price: ₹ 57,708.49

Antigen

EPCR

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Procr

Gene Alias

Activated protein C receptor; AI325044; APC receptor; bA42O4.2; CCCA; CCD41; CD antigen CD201; CD201; CD201 antigen; cell cycle, centrosome-associated protein; centrocyclin; Centrosomal protein CCD41; endothelial cell protein C receptor; Endothelial protein C receptor; Epcr; PROCR; protein C receptor; protein C receptor, endothelial

Host Species

Rabbit

Purification Method

Ammonium sulfate precipitation, Size-exclusion - Dialysis

Regulatory Status

RUO

Gene ID (Entrez)

10544

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Form

Liquid

Applications

Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot

Concentration

2 mg/mL

Formulation

PBS with 0.09% sodium azide

Gene Accession No.

Q9UNN8

Gene Symbols

Procr

Immunogen

KLH conjugated synthetic peptide between 104-132 amino acids from the central region of human CD201

Quantity

400 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA512513

--

Img

Thermo Scientific

PIPA514382

--

Img

Thermo Scientific

PIPA512448

--

Img

Thermo Scientific

PIPA512514

--

Img

Thermo Scientific

PIPA514280

--

Img

Thermo Scientific

PIPA512185

--

Img

Thermo Scientific

PIPA514372

--

Img

Thermo Scientific

PIPA512467

--

Description

  • The protein encoded by this gene is a receptor for activated protein C, a serine protease activated by and involved in the blood coagulation pathway
  • The encoded protein is an N-glycosylated type I membrane protein that enhances the activation of protein C
  • Mutations in this gene have been associated with venous thromboembolism and myocardial infarction, as well as with late fetal loss during pregnancy.